Dr. Chan Park, MD

NPI: 1619940681
Total Payments
$231.93
2024 Payments
$78.15
Companies
5
Transactions
12

Payment Breakdown by Category

Food & Beverage$231.93 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $231.93 12 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $77.80 5 $0 (2021)
Dexcom, Inc. $63.04 2 $0 (2024)
GlaxoSmithKline, LLC. $40.52 2 $0 (2020)
ABBVIE INC. $33.19 2 $0 (2024)
Novo Nordisk Inc $17.38 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $78.15 3 Dexcom, Inc. ($63.04)
2023 $17.38 1 Novo Nordisk Inc ($17.38)
2022 $18.08 1 ABBVIE INC. ($18.08)
2021 $35.50 2 Janssen Pharmaceuticals, Inc ($35.50)
2020 $82.82 5 Janssen Pharmaceuticals, Inc ($42.30)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/05/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $25.94 General
Category: Endocrinology
09/26/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $37.10 General
Category: Endocrinology
09/18/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.11 General
Category: NEUROSCIENCE
09/13/2023 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $17.38 General
Category: Diabetes
04/14/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.08 General
Category: NEUROSCIENCE
04/01/2021 Janssen Pharmaceuticals, Inc INVOKANA (Drug), XARELTO Food and Beverage In-kind items and services $13.54 General
Category: Cardiovascular & Metabolism
01/28/2021 Janssen Pharmaceuticals, Inc INVOKANA (Drug), XARELTO Food and Beverage In-kind items and services $21.96 General
Category: Cardiovascular & Metabolism
10/20/2020 Janssen Pharmaceuticals, Inc INVOKANA (Drug), XARELTO Food and Beverage In-kind items and services $11.20 General
Category: Cardiovascular & Metabolism
08/06/2020 Janssen Pharmaceuticals, Inc INVOKANA (Drug), XARELTO Food and Beverage In-kind items and services $15.42 General
Category: Cardiovascular & Metabolism
07/13/2020 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.13 General
Category: RESPIRATORY
04/30/2020 Janssen Pharmaceuticals, Inc INVOKANA (Drug), XARELTO Food and Beverage In-kind items and services $15.68 General
Category: Cardiovascular & Metabolism
04/02/2020 GlaxoSmithKline, LLC. SHINGRIX (Biological) Food and Beverage In-kind items and services $24.39 General
Category: VACCINES

About Dr. Chan Park, MD

Dr. Chan Park, MD is a Emergency Medicine healthcare provider based in Williamsburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619940681.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chan Park, MD has received a total of $231.93 in payments from pharmaceutical and medical device companies, with $78.15 received in 2024. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($231.93).

Practice Information

  • Specialty Emergency Medicine
  • Location Williamsburg, VA
  • Active Since 02/09/2006
  • Last Updated 08/07/2008
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1619940681

Products in Payments

  • INVOKANA (Drug) $77.80
  • Dexcom G6 Transmitter (Medical Supply) $63.04
  • VRAYLAR (Drug) $33.19
  • SHINGRIX (Biological) $24.39
  • Ozempic (Drug) $17.38
  • TRELEGY ELLIPTA (Drug) $16.13

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Williamsburg